Induction of pulmonary fibrosis in organ-cultured rat lung by cadmium chloride and transforming growth factor-beta1.
Cadmium chloride (CdCl2) exposure has been reported to induce pulmonary fibrosis in rats. Accumulating evidence has shown that cytokines play a pivotal role in the excessive production of connective tissue components in pulmonary fibrosis. In this report, rat lung slice cultures were used to study the synergistic involvement of transforming growth factor-beta1 (TGF-beta1) in CdCl2-induced alveolar fibrosis. Rat lung slices were maintained at the interphase of air and medium on a polyester mesh stretched on a plastic scaffold. Treatment of lung slices with 2.5, 5 or 10 microM CdCl2 for 7 days resulted in 85, 40 and 6% respectively for relative survival. Under these culture conditions, CdCl2 alone did not induce alveolar fibrosis in rat lung slices. However, in the presence of 0.5 ng/ml TGF-beta1, CdCl2 at a dose ranging from 1 to 5 microM increased the thickness of alveolar septa. Furthermore, the thickness of alveolar septa in lung slices treated with CdCl2 was dose-dependently increased by the presence of TGF-beta1. The thickened alveolar septa were apparently due to the deposition of excessive extracellular matrix, as revealed by trichrome stain and ultrastructural examination. Our results also show that fibrogenic activity induced by the combined treatment with CdCl2 and TGF-beta1 can be reduced by co-treatment with 200 microg/ml lambda-carrageenan, a TGF-beta1 inhibitor. Therefore, the present results indicate that TGF-beta1 can synergistically stimulate the fibrogenic activity in lung tissue subsequent to CdCl2 injury.
Lin
C J
CJ
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.
Yang
P C
PC
Hsu
M T
MT
Yew
F H
FH
Liu
T Y
TY
Shun
C T
CT
Tyan
S W
SW
Lee
T C
TC
D000818:Animals; D001391:Azo Compounds; D019256:Cadmium Chloride / Q000633:toxicity*; D002351:Carrageenan / Q000494:pharmacology; D004396:Coloring Agents; D004357:Drug Synergism; D004801:Eosine Yellowish-(YS); D005109:Extracellular Matrix / Q000187:drug effects / Q000473:pathology; D008168:Lung / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D008739:Methyl Green; D009924:Organ Culture Techniques; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D016707:Tissue Fixation; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000633:toxicity*
D001391:Azo Compounds; D004396:Coloring Agents; D016212:Transforming Growth Factor beta; C017768:trichrome stain; D008739:Methyl Green; D002351:Carrageenan; D019256:Cadmium Chloride; D004801:Eosine Yellowish-(YS)